
AI News
GSK and Relation Therapeutics expand AI drug discovery partnership
GSK has committed up to $110 million to a research collaboration with British biotech firm Relation Therapeutics, aiming to integrate proprietary biological data generation with AI-driven drug discovery. The partnership focuses on training advanced models to identify new therapeutic targets by mapping how human cells respond to genetic interventions.























